For the quarter ending 2026-03-31, XTNT made $20,884K in revenue. -$3,089K in net income. Net profit margin of -14.79%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| total revenue | 20,884 | 32,357 | 33,255 | 35,411 |
| Cost of sales | 8,913 | 14,603 | 11,263 | 11,127 |
| Gross profit | 11,971 | 17,754 | 21,992 | 24,284 |
| General and administrative | 6,273 | 7,293 | 7,071 | 7,478 |
| Sales and marketing | 8,186 | 10,946 | 11,746 | 11,616 |
| Research and development | 435 | 459 | 634 | 566 |
| Total operating expenses | 14,894 | 18,698 | 19,451 | 19,660 |
| (gain) income from operations | -2,923 | -944 | 2,541 | 4,624 |
| Interest expense | 599 | 718 | 904 | 1,004 |
| Interest income | 219 | 24* | - | - |
| Unrealized foreign currency translation (loss) gain | -1 | -206 | -56 | 178 |
| Gain on divestiture | - | 3,356* | - | - |
| Other income (expense) | 242 | 87* | -16 | 7 |
| Total other expense | -139 | 2,542 | -976 | -819 |
| Net (loss) income from operations before provision for income taxes | -3,062 | 1,598 | 1,565 | 3,805 |
| (provision) benefit for income taxes current and deferred | 27 | 1,541 | 257 | 255 |
| Net (loss) income | -3,089 | 57 | 1,308 | 3,550 |
| Basic EPS | -0.02 | 0 | 0.01 | 0.03 |
| Diluted EPS | -0.02 | 0 | 0.01 | 0.02 |
| Basic Average Shares | 140,058,787 | 140,034,775 | 139,712,969 | 139,310,589 |
| Diluted Average Shares | 140,058,787 | 157,883,634 | 150,377,234 | 148,574,242 |
Xtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc. (XTNT)